- Home
- BGI vs IRIX Comparison
BGI vs IRIX Comparison
Compare BGI & IRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGI
- IRIX
- Stock Information
- Founded
- BGI 1879
- IRIX 1989
- Country
- BGI Canada
- IRIX United States
- Employees
- BGI N/A
- IRIX N/A
- Industry
- BGI
- IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- BGI
- IRIX Health Care
- Exchange
- BGI Nasdaq
- IRIX Nasdaq
- Market Cap
- BGI 31.1M
- IRIX 28.6M
- IPO Year
- BGI 2005
- IRIX 1996
- Fundamental
- Price
- BGI $1.60
- IRIX $1.64
- Analyst Decision
- BGI
- IRIX Hold
- Analyst Count
- BGI 0
- IRIX 1
- Target Price
- BGI N/A
- IRIX $2.00
- AVG Volume (30 Days)
- BGI 15.5K
- IRIX 29.8K
- Earning Date
- BGI 12-31-2024
- IRIX 11-12-2024
- Dividend Yield
- BGI N/A
- IRIX N/A
- EPS Growth
- BGI N/A
- IRIX N/A
- EPS
- BGI N/A
- IRIX N/A
- Revenue
- BGI $131,596,264.00
- IRIX $48,431,000.00
- Revenue This Year
- BGI N/A
- IRIX N/A
- Revenue Next Year
- BGI N/A
- IRIX $5.44
- P/E Ratio
- BGI N/A
- IRIX N/A
- Revenue Growth
- BGI 4.01
- IRIX N/A
- 52 Week Low
- BGI $1.46
- IRIX $1.27
- 52 Week High
- BGI $4.88
- IRIX $3.65
- Technical
- Relative Strength Index (RSI)
- BGI 37.69
- IRIX 43.85
- Support Level
- BGI $1.58
- IRIX $1.61
- Resistance Level
- BGI $1.67
- IRIX $1.89
- Average True Range (ATR)
- BGI 0.09
- IRIX 0.10
- MACD
- BGI 0.02
- IRIX -0.02
- Stochastic Oscillator
- BGI 33.31
- IRIX 8.82
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
About IRIX IRIDEX Corporation
IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.